Empagliflozin for reducing the risk of cardiovascular events in type 2 diabetes [ID1037]

  • Discontinued
  • GID-TA10177

Documents

Documents created during the development process.

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators